Hydroxyzine
| Clinical data | |
|---|---|
| Pronunciation | /haɪˈdrɒksɪziːn/ |
| Trade names | Atarax,[1] Vistaril,[2] others |
| Other names | UCB-4492 |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a682866 |
| License data |
|
| Dependence liability | None[3] |
| Routes of administration | By mouth, intramuscular |
| Drug class | First-generation antihistamine[4] |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | High |
| Protein binding | 93% |
| Metabolism | Liver |
| Metabolites | Cetirizine, others |
| Elimination half-life | Adults: 20.0 hours[5][6] Elderly: 29.3 hours[7] Children: 7.1 hours[5] |
| Excretion | Urine, feces |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank |
|
| ChemSpider | |
| UNII |
|
| KEGG | |
| ChEBI |
|
| ChEMBL |
|
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.000.630 |
| Chemical and physical data | |
| Formula | C21H27ClN2O2 |
| Molar mass | 374.91 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| (verify) | |
Hydroxyzine, sold under the brand names Atarax and Vistaril among others, is an antihistamine medication.[8] It is used in the treatment of itchiness, anxiety, insomnia, and nausea (including that due to motion sickness).[8] It is used either by mouth or injection into a muscle.[8]
Hydroxyzine works by blocking the effects of histamine.[9] It is a first-generation antihistamine in the piperazine family of chemicals.[8][4] Common side effects include sleepiness, headache, and dry mouth.[8][9] Serious side effects may include QT prolongation.[9] It is unclear if use during pregnancy or breastfeeding is safe.[8]
It was first made by Union Chimique Belge in 1956 and was approved for sale by Pfizer in the United States later that year.[8][10] In 2022, it was the 46th most commonly prescribed medication in the United States, with more than 13 million prescriptions.[11][12]
- ^ "Atarax: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Retrieved 25 March 2023.
- ^ "Vistaril: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Archived from the original on 1 May 2017. Retrieved 5 August 2020.
- ^ Hubbard JR, Martin PR (2001). Substance Abuse in the Mentally and Physically Disabled. CRC Press. p. 26. ISBN 9780824744977.
- ^ a b "Hydroxyzine". United States National Library of Medicine (NLM). Retrieved 4 March 2020.
- ^ a b Cite error: The named reference
pmid2866055was invoked but never defined (see the help page). - ^ Cite error: The named reference
pmid6141198was invoked but never defined (see the help page). - ^ Cite error: The named reference
pmid2562944was invoked but never defined (see the help page). - ^ a b c d e f g "Hydroxyzine Hydrochloride Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 21 November 2018.
- ^ a b c British national formulary : BNF 74 (74 ed.). British Medical Association. 2017. p. X. ISBN 978-0857112989.
- ^ Shorter E (2009). Before Prozac: the troubled history of mood disorders in psychiatry. Oxford [Oxfordshire]: Oxford University Press. ISBN 9780195368741.
- ^ "The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
- ^ "Hydroxyzine Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. Retrieved 30 August 2024.